Home＞ACADEMIA
JSNP Finalizes Evidence-Based Guidelines for Treatment of Schizophrenia(Sep.28.2015)
(LOG IN FOR FULL STORY)
-
- Japanese Society of Medical Oncology to Update I/O Guidelines in October Jul.18
- Hematologist Optimistic about New Drugs for AML Including SMO and BCL-2 Inhibitors as Well as FLT3 Inhibitors Jul.11
-
Doctors Need Solid Understanding of Hereditary Cancer When Prescribing Lynparza for Breast Cancer: Prof.
Jul.05
- Anti-TNF-α Antibody Treatment for Crohn’s Disease Costs 1.95 Million Yen per Patient Annually: Study Jun.27
- Licensee Selection Draws Near for AMED-Backed Cancer Mouth Sores Treatment Jun.26
- Subcutaneous Vedolizumab Hits Primary Endpoint in PIII: Takeda(Jul.20)
- Takeda, Ovid Launching 3 New Studies for Rare Epilepsy Drug(Jul.20)
- Steep Hikes in Prices of Chinese-Made APIs Could Hit Generic Makers Hard(Jul.20)
- Rare Disease Pharmaceuticals in Japan to See New Demand for Skilled Human Resources(Jul.20)
- Fuji Pharma Poised to Develop New Biosimilar in Women’s Health/Acute Care(Jul.19)
